Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AKR1B10-IN-1, a powerful AKR1B10 (Aldo-Keto Reductase 1B10) inhibitor, demonstrates an IC50 value of 3.5 nM. This compound effectively curtails the proliferation, metastasis, and Cisplatin (CDDP) resistance of lung cancer cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | AKR1B10-IN-1, a powerful AKR1B10 (Aldo-Keto Reductase 1B10) inhibitor, demonstrates an IC50 value of 3.5 nM. This compound effectively curtails the proliferation, metastasis, and Cisplatin (CDDP) resistance of lung cancer cells. |
Targets&IC50 | AKR1B10:3.5 nM , AKR1B1:277 nM |
In vitro | AKR1B10-IN-1 (compound 4e), at concentrations ranging from 0 to 20 μM over 96 hours, effectively inhibits the growth of both A549 and AKR1B10-stably overexpressing A549 cells (A549/1B10), demonstrating a potent ability to hinder cell proliferation attributed to both overexpressed and endogenous AKR1B10. Additionally, at concentrations up to 40 μM, with a 2-hour pre-treatment followed by a 24-hour incubation with cisplatin (CDDP), AKR1B10-IN-1 significantly reduces cell viability in cisplatin-resistant A549 cells (CDDP-R-A549) in a dose-responsive manner. Cell viability assays confirm these effects, showing a statistically significant suppression in A549 and A549/1B10 cell growth at 20 μM and a noticeable decrease in viability of CDDP-R-A549 cells, particularly at 40 μM, after pretreatment with AKR1B10-IN-1 followed by CDDP exposure. |
Synonyms | AKR1B10-IN-1 |
Molecular Weight | 341.338 |
Formula | C19H16FNO4 |
CAS No. | 2136579-33-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AKR1B10-IN-1 2136579-33-2 AKR1B10 IN 1 AKR1B10IN1 AKR-1B10-IN-1 inhibitor inhibit